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Bordetella pertussis, the causative agent of human whooping cough (pertussis) produces a complex array of virulence
factors in order to establish efﬁcient infection in the host. The RNA chaperone Hfq and small regulatory RNAs are key
players in posttranscriptional regulation in bacteria and have been shown to play an essential role in virulence of a
broad spectrum of bacterial pathogens. This study represents the ﬁrst attempt to characterize the Hfq regulon of the
human pathogen B. pertussis under laboratory conditions as well as upon passage in the host and indicates that loss of
Hfq has a profound effect on gene expression in B. pertussis. Comparative transcriptional proﬁling revealed that Hfq is
required for expression of several virulence factors in B. pertussis cells including the Type III secretion system (T3SS). In
striking contrast to the wt strain, T3SS did not become operational in the hfq mutant passaged either through mice or
macrophages thereby proving that Hfq is required for the functionality of the B. pertussis T3SS. Likewise, expression of
virulence factors vag8 and tcfA encoding autotransporter and tracheal colonization factor, respectively, was strongly
reduced in the hfq mutant. Importantly, for the ﬁrst time we demonstrate that B. pertussis T3SS can be activated upon
contact with macrophage cells in vitro.
Introduction
Bordetella pertussis is a Gram-negative bacterial pathogen of
the human respiratory tract and causative agent of whooping
cough (pertussis). Infection by B. pertussis is especially severe in
infants and despite vaccination, B. pertussis remains a major cause
of children mortality worldwide, predominantly in developing
countries.1-3 However, pertussis is now on the rise also in devel-
oped countries and is reemerging in some highly vaccinated pop-
ulations.3-5 The increase in pertussis cases has been mostly
attributed to short-lived immunity induced by the acellular vac-
cine and escape from immunity due to pathogen adaptation and
antigen variation.6-9 Therefore, there is an urgent need for a bet-
ter understanding of molecular mechanisms underlying the
pathogenesis of B. pertussis infection that would lead to identifica-
tion of novel factors as potential components of new vaccine
formulations.10,11
In order to successfully infect the host, B. pertussis produces
a broad spectrum of virulence factors including filamentous
hemagglutinin, pertactin, fimbriae, pertussis toxin and adenylate
cyclase toxin.1,12 The type III secretion system (T3SS) allowing
injection of proteins referred to as effectors directly into the
cytosol of eukaryotic host cells has also been identified in Bor-
detella subspecies.13,14 The T3SS is a supramolecular structure
consisting of an inner membrane export apparatus, a basal
body that spans from inner to the outer membrane, an extracel-
lular needle and the needle tip (translocon) complex.15,16 In the
closely related B. bronchiseptica, this “injectisome” is composed
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of approximately 30 proteins including chaperones and effectors
which are encoded by the bsc locus.13 Bordetella T3SS repre-
sents an important virulence factor as it subverts innate and
adaptive immune responses of the host and is required for long
term colonization of trachea of rats and mice.13,17,18 Although
the T3SS of B. pertussis is highly homologous to that of B.
bronchiseptica and bsc genes are actively transcribed,19,20 labora-
tory-adapted high-passage B. pertussis strains like Tohama I do
not produce and secrete T3SS substrates when grown in
vitro.20-22 However, the functionality of T3SS can be reverted
upon contact with the host as evidenced by production of the
T3SS tip complex protein Bsp22 in B. pertussis cells recovered
from infected mice.22 Intriguingly, the T3SS activation is
reversible as the production of Bsp22 protein is lost again after
successive in vitro passages.22 Bsp22 is the most abundant
T3SS substrate secreted by B. bronchiseptica and is considered
as a hallmark of T3SS functionality.18 Deletion of bsp22 gene
in B. bronchiseptica disrupts T3SS-mediated cytotoxicity and
affects colonization levels and persistence in the lower respira-
tory tract of mice.18 Interestingly, production of Bsp22 was
observed also in fresh clinical isolates of B. pertussis, thereby fur-
ther confirming that contact with the host is crucial for switch-
ing on the expression of T3SS.21,22
The expression of the majority of B. pertussis virulence factors
is controlled at transcriptional level by a two-component system
encoded by the bvg locus (for a review see ref.23). This consists of
the transmembrane sensor kinase BvgS and of the DNA-binding
response regulator BvgA which in its phosphorylated form binds
to promoter regions and activates transcription of dependent vir-
ulence genes.24,25 Expression of the bsc locus is regulated at both
transcriptional and posttranscriptional levels by the BvgAS sys-
tem and by factors encoded by the btr locus which is adjacent to
bsc genes20 (Fig. 1A). The BtrS protein whose production is
tightly activated by the BvgAS system bears homology to the
family of extracytoplasmic function sigma factors and is required
for transcription of bsc and btr loci. BtrU, BtrV and BtrW factors
carry high similarity to a partner switching module known in
Gram-positive bacteria and are required for secretion and stabil-
ity of T3SS substrates.20
In many pathogenic bacteria the RNA chaperone Hfq and
small non-coding regulatory RNAs (sRNAs) emerged as key
players in posttranscriptional regulation of virulence and phys-
iological fitness.26,27 Posttranscriptional regulation of B. per-
tussis virulence has not yet been studied extensively, however,
several sRNA were identified in B. pertussis28 and recently, we
have shown that the RNA chaperone Hfq is required for viru-
lence of B. pertussis.29 The Tohama I Dhfq strain produced
decreased amounts of adenylate cyclase toxin and secreted
reduced amounts of pertussis toxin. Consequently, the hfq
mutant was clearly attenuated in the mouse respiratory model
of infection as its lethality as well as its capacity to colonize
mouse lungs was strongly reduced when compared to the wt
strain. These data encouraged us to apply microarray analysis
in order to evaluate the global impact of hfq deletion on gene
expression with specific focus on virulence. Through differen-
tial analysis of expression profiles of laboratory-adapted and
mouse-passaged wt and Dhfq strains we aimed at the identifi-
cation of Hfq regulon in B. pertussis. In this work we show
that loss of Hfq function has a deep impact on expression of
several virulence factors including T3SS. Our data clearly indi-
cate that Hfq is strongly required for functionality of T3SS in
B. pertussis.
Results
Hfq affects global gene expression in B. pertussis
To evaluate the effect of hfq deletion on global gene expres-
sion profiles, DNA microarrays covering 3554 B. pertussis pro-
tein-coding genes were hybridized with total RNA purified from
wt and Dhfq cells grown to exponential and stationary phase of
growth. A cutoff of at least twofold variation in expression
(log2FC >1; <¡1; P < 0.05) was applied to identify genes with
significant changes in transcript abundance between wt strain
and hfq mutant. In the exponential phase, 368 genes (10.6%)
fulfilled these criteria and displayed differences in transcript
abundance (Fig. 1B and Table S1). Among them, 212 genes
were downregulated and 156 upregulated in the Dhfq strain. In
the stationary phase, the transcriptional profiles exhibited similar
pattern with 351 (10.1%) significantly affected genes (Table S2).
Among them, 186 genes were downregulated and 165 upregu-
lated. Functional class categorization of filtered Hfq-dependent
genes showed significant enrichment (P < 0.05) in some gene
categories (Fig. 1B). In the exponential phase, “Energy metabo-
lism” was the only functional category significantly enriched for
Hfq-dependent genes (20.9%; P < 0.002) since the
“Pathogenicity and Adaptation” category did not reach the statis-
tical significance (14.0%; P D 0.054). In the stationary phase,
genes related to “Pathogenicity and Adaptation” (13.6%; P <
0.05) and “Information transfer” (15.1%; P < 0.015) categories
were significantly overrepresented. Notably, in the exponential
and stationary phase 80% (28/35) and 88% (30/34) of genes
related to “Pathogenicity and adaptation” category were downre-
gulated in the hfq mutant, respectively, being fully in accordance
with reduced virulence of the mutant. Interestingly, a large por-
tion of affected genes (17/25 and 20/36, respectively) within
“Information transfer” category belonged to genes encoding 30S
and 50S ribosomal proteins. While not significantly enriched,
the highest numbers (125 and 110, respectively) of affected genes
were related to largest functional category of “Surface proteins.”
Besides large number of genes predicted to encode putative mem-
brane proteins this group also included several genes encoding
ATP binding cassette (ABC) transport proteins which expression
in the exponential phase was largely upregulated in the mutant
(Tables S1 and S2). Interestingly, 16 of 19 genes (84.2%) associ-
ated with regulatory function were downregulated in the Dhfq
strain in the exponential phase.
Lack of Hfq results in reduced expression of several virulence
genes including T3SS
Within the set of genes related to pathogenicity and displaying
significantly lower transcript levels in the mutant regardless of the
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growth phase, we identified the T3SS bsc gene cluster (Fig. 1C).
Among the significantly downregulated genes were bsp22, bopD
and bopN encoding the T3SS tip complex protein, the pore-
forming translocator protein and the T3SS effector, respectively.
In contrast, the expression of the btr locus which comprises T3SS
regulatory genes was not significantly affected. Notably, expres-
sion of bteA and btcA genes which are not part of the bsc locus
and encode another T3SS effector protein BteA and its chaper-
one BtcA, respectively, was also significantly downregulated in
the hfq mutant. Similarly, expression of other virulence genes
Figure 1. Comparative transcriptomic analysis of laboratory-adapted wt and Dhfq strains of B. pertussis. (A) Genomic organization and open reading
frames of the Type III secretion cluster in B. pertussis. The genes comprising both bsc and regulatory btr loci are presented as arrows. The drawing was cre-
ated using CLC Sequence viewer version 6.6.2 (CLC bio A/S). (B) Functional categorization of genes signiﬁcantly affected by loss of Hfq function. Data are
expressed as numbers of genes within category which were signiﬁcantly down- (green bars) or upregulated (red bars) in the hfq mutant cells grown to
exponential (E) or stationary (S) phase of growth. Total numbers of B. pertussis genes associated with a speciﬁc category are shown in brackets. Signiﬁ-
cantly overrepresented functional categories are depicted with asterisks, P ˂ 0.05. (C) Changes in transcript abundance patterns of selected virulence fac-
tors in B. pertussis. The heat map presents comparison of gene expression proﬁles between Dhfq and wt cells (log2FC Dhfq/wt) grown to exponential (E)
or stationary (S) phase as determined by microarray analysis. Data are averaged from 2 biological replicates, each gene is represented by 2 array ele-
ments. All expression proﬁles are in rows and are represented using the color scale on the top. (D) RT-qPCR analysis of bsp22, bteA, vag8 and brkA tran-
script levels in wt and Dhfq cells. Total RNA was isolated from cells grown to exponential (E; white columns) and stationary (S; gray columns) phases and
RT-qPCR was performed using primers speciﬁc for bsp22, bteA, vag8 and brkA genes. Target expression levels in wt and Dhfq cells were normalized to
the reference gene rpoB and the wt/Dhfq expression ratios were calculated. The values are means plus standard deviations from 3 experiments. (E) West-
ern blot analysis of Vag8 and BrkA protein levels in Tohama I wt and Dhfq strain. Both strains were grown in SS medium and cells were harvested at expo-
nential (E) and stationary (S) phase. Samples of cell lysates equivalent to 0.1 OD600 unit of initial culture were separated on 10% SDS-PAGE gel and
analyzed by immunoblotting using anti-Vag8 and anti-BrkA antibodies. Relevant parts of the membranes are shown. The result is representative of 3
experiments.
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including vag8 autotransporter, serum resistance gene brkA (only
in the exponential phase) and tracheal colonization factor tcfA
was also significantly decreased in the mutant strain, suggesting
that Hfq has an impact on a broad spectrum of virulence genes
(Fig. 1C). In contrast to the majority of virulence genes and in
agreement with our previous data,29 the ptx/ptl locus was signifi-
cantly upregulated in the hfq mutant (Tables S1 and S2).
In order to verify our microarray data, we have analyzed tran-
script levels of several virulence genes including the T3SS locus.
We have quantified the levels of the bsp22, bteA, vag8 and brkA
transcripts in both wt and Dhfq strains of B. pertussis by RT-
qPCR. As shown in Figure 1D, the relative expression levels of
bsp22, bteA, vag8 and brkA genes were decreased in the hfq
mutant thereby confirming our microarray data. Furthermore,
Western blot analysis of wt and Dhfq cell lysates showed that lev-
els of Vag8 and BrkA proteins mirrored the relative transcript
levels and thereby provided another layer of evidence for credibil-
ity of our microarray data (Fig. 1E).
Hfq is required for regained production of Bsp22 protein
upon passage in mice
Transcriptional profiling of wt and Dhfq strains adapted to
laboratory culture conditions suggested that Hfq is required for
expression of several virulence factors including T3SS. Therefore,
we asked whether the differential expression of the T3SS locus
would have an impact on production of T3SS components. Lab-
oratory-adapted B. pertussis strains like Tohama I do not produce
T3SS substrates under standard in vitro conditions, however,
Gaillard and coworkers have shown that after passage through
mice the recovered Tohama I cells produced Bsp22 into SS
medium and kept the production for 3 additional passages in
vitro.22 Therefore, we decided to passage both strains in mice
and monitor their ability to produce and secrete the T3SS tip
complex protein Bsp22 (marker of T3SS functionality).Toward
this aim, CD-1 mice were infected with sublethal doses of both
wt and Dhfq strain (1 £ 105 CFU/mouse) and colonization pro-
files of both strains were examined over 23 days. As illustrated by
Figure 2A and in line with our previous observations,29 the wt
strain was able to proliferate in lungs and its CFU counts
increased by more than one order of magnitude within 8 days of
infection whereas the hfq mutant was unable to multiply and was
cleared from mouse lungs with a significantly higher efficacy. In
the course of the infection, the viable wt and Dhfq bacteria were
recovered from mouse lungs at each experimental time point,
subcultivated in SS medium and assayed for Bsp22 accumulation
in whole-cell lysates and in culture supernatants. As shown in
Figure 2B, Bsp22 protein accumulated in whole cell lysates as
well as in culture supernatants of mouse-passaged wt bacteria
recovered at days 8, 12 and 23 post infection. Strikingly, Bsp22
protein was absent in cell lysates and culture supernatants of pas-
saged Dhfq bacteria. These results indicated that Hfq is required
for both expression and production of Bsp22 and consequently,
for T3SS function in B. pertussis.
Transcriptional profiling of passaged strains confirms
requirement of Hfq for virulence
Next, we assumed that transcriptional profiling of wt and
Dhfq bacteria passaged in mice would not only allow us to further
corroborate the effect of hfq deletion on production of T3SS
components but could also enlighten the global contribution of
Hfq to B. pertussis adaptation and survival during infection.
Therefore, in order to elaborate this assumption, total RNA was
purified from wt and Dhfq bacteria recovered at days 0 and 12
post infection and used for microarray analysis to determine
changes in gene expression occurring upon passage in mice. A
cutoff of at least twofold variation in expression (log2FC >1;
<¡1; P < 0.05) between
wt and hfq mutant strains
(Dhfq versus wt at day 0
and at day 12) or in the
course of infection (day
12 vs. day 0 for both
strains) was applied to
identify genes with signifi-
cant changes in transcript
abundance. Comparison
of expression profiles of
both strains at day 0
revealed 346 (10.1%) sig-
nificantly affected genes
(Fig. 3A, left histogram)
showing a distribution
into functional categories
similar to our initial
experiment (Fig. 1B). In
the hfq mutant, 198 genes
were downregulated and
148 genes were upregu-
lated when compared to
Figure 2. Hfq is required for Bsp22 and Vag8 production in B. pertussis. (A) Colonization of mouse lungs after intrana-
sal challenge with the wt or Dhfq strain. 15 mice/strain were infected intranasally with 1 £ 105 CFU/mouse and groups
of 3 animals were sacriﬁced 2 h (day 0) and 5, 8, 12 and 23 days after infection. Lung homogenates were plated in
duplicates on BGA plates and CFU of the wt () and Dhfq () strains were counted. The values are means plus standard
deviations. *, P˂ 0.05; **, P˂ 0.01 (Dhfq versus wt). The dashed line represents the limit of detection. (B) Westernblot
analysis of Bsp22 and Vag8 protein levels in the wt or Dhfq strains recovered from lung homogenates in the course of
colonization experiment (see panel A). Samples equivalent to 0.1 OD600 unit (pellets, P) or 1 OD600 unit (supernatants,
S) of initial culture were analyzed by immunoblotting using anti-Bsp22 and anti-Vag8 antibodies. Relevant parts of the
membranes are shown.
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the wt strain (Table S3). None of the functional categories was
enriched significantly, however, categories “Energy metabolism”
(14.7%; P D 0.062), “Information transfer” (13%; P D 0.074)
and “Pathogenicity and Adaptation” (13.2%; P D 0.058) were
highly represented. Within the latter category, expression of
majority of the bsc locus and bteA and vag8 genes was signifi-
cantly diminished in the hfqmutant. The difference in expression
of these virulence factors became even more apparent when we
compared the transcriptomic profiles of wt and Dhfq bacteria
recovered 12 days post infection (Table S4). As indicated in
Figure 3A (right histogram), the total number of affected genes
(359, 10.4%) did not surprisingly differ from day 0, however,
the “Pathogenicity and Adaptation” category became the only
significantly overrepresented functional category (18.4%;
P < 1 £ 10¡4) with 40 out of 46 genes downregulated in the hfq
mutant. Likewise, 12 days post infection the difference in expres-
sion of vag8 and T3SS-specific genes between wt and Dhfq strains
further increased (Fig. 3B). Interestingly, expression of the btrU
gene which plays a role in secretion of T3SS substrates was also
significantly downregulated in the hfq mutant upon infection. In
addition, genes involved in iron metabolism such as bhuU and
BP0546 encoding hemin permease and bacterioferritin, respec-
tively, also exhibited lower transcript levels in the Dhfq strain at
day 12 (Table S4). Within the set of genes observed to have sig-
nificantly higher transcript levels in the hfq mutant 12 days post
infection were bvgR and fim2 encoding BvgR regulatory factor
and serotype 2 fimbrial subunit, respectively.
When compared to wt strain, relative abundance of bsp22, bteA,
bopN and vag8 transcripts as determined by RT-qPCR (Fig. 3C) was
highly decreased in the Dhfq strain and this trend was further intensi-
fied in samples collected at day 12 post infection, thereby confirming
the output of microarray data. In addition, Vag8 levels were deter-
mined in cell lysates of both passaged strains byWesternblot analysis.
As seen in Figure 2B and in agreement with microarray and
Figure 3. Comparative transcriptomic analysis of mouse-passaged wt and Dhfq strains. (A) Functional categorization of genes signiﬁcantly affected by
loss of Hfq function in B. pertussis cells recovered at day 0 (D0) and at day 12 (D12) post infection. Data are expressed as numbers of genes within cate-
gory which were signiﬁcantly down- (green bars) or upregulated (red bars) in the hfq mutant. Total numbers of B. pertussis genes associated with a spe-
ciﬁc category are shown in brackets. Signiﬁcantly overrepresented functional categories are depicted with asterisks, P ˂ 0.05. (B) Changes in transcript
abundance patterns of selected virulence factors in B. pertussis. The heat map presents comparison of gene expression proﬁles between Dhfq and wt
cells recovered (log2FC Dhfq/wt) at day 0 and day 12 post infection as determined by microarray analysis. All expression proﬁles are in rows and are rep-
resented using the color scale on the top, each gene is represented by 2 array elements. (C) RT-qPCR analysis of bsp22, bteA, bopN and vag8 transcript
levels in wt and Dhfq bacteria upon infection. Differential expression analysis was performed using total RNA isolated from wt and Dhfq bacteria recov-
ered from infected mice at day 0 (white columns) and day 12 (gray columns). The values are means plus standard deviations from 3 replicates.
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RT-qPCR data, the hfq mutant produced significantly reduced
amounts of Vag8 protein while the Vag8 production in wt strain was
further increased upon infection.
In order to characterize the infection-associated changes in
gene expression in individual strains we have also compared tran-
scriptional profiles in RNA samples collected at day 12 and day 0
in both wt and Dhfq strains by microarray analysis using the
same threshold parameters (Fig. S1A). Comparison of transcript
levels determined at day 12 with those obtained at day 0 revealed
115 and 78 genes to be affected in the wt and Dhfq strain, respec-
tively (Fig. S1A, Tables S5 and S6). This analysis showed that
upon contact with the host the T3SS-specific genes as well as the
vag8 gene are significantly upregulated in the wt strain
(Fig. S1B). This pattern of expression was observed also in the
hfq mutant although to a much lower extent. Notably, expression
of the btrS gene encoding T3SS regulatory factor was upregulated
in both strains while transcript levels of btrU were increased only
in the wt strain. Relative transcript levels of selected genes as
determined by RT-qPCR were in agreement with microarray
data. In contrast to Dhfq strain, the expression levels of bsp22,
bteA, bopN and vag8 genes assessed in wt bacteria recovered at
day 12 were increased when compared to those recovered at day
0 (Fig. S1C).
Hfq is required for expression of T3SS in B. pertussis cells
recovered from infected macrophages
Our data indicated that Hfq is required for T3SS activation in
mouse-passaged bacteria. During infection, resident and
infiltrating macrophages are
one of the first cells of the
innate immune system to
sense B. pertussis cells and
thus play a very important
role in the clearance of the
pathogen.30,31 Therefore,
we asked if the contact with
macrophages in vitro would
be sufficient for activation
of T3SS in B. pertussis cells.
Thus, in order to corrobo-
rate this hypothesis, we
infected RAW 264.7 mac-
rophages with wt and Dhfq
bacteria and viable bacteria
were recovered 24 and
48 hours post infection.
Control bacteria which
were not in contact with
macrophages (time 0)
together with recovered
bacteria were further sub-
cultivated in SS medium
and culture supernatants
were tested for presence of
the Bsp22 protein. As
shown in Figure 4A, wt
cells recovered at both time points produced Bsp22 while the
Dhfq cells did not. This result indicated that upon contact with
macrophage cells the functionality of T3SS (assessed as produc-
tion of Bsp22 protein) can be regained only in wt bacteria and
that similarly to mouse-passaged bacteria, the production of
Bsp22 can be observed in subsequent in vitro cultures of recov-
ered bacteria. In order to further refine our observation, we have
repeated macrophage infection experiment only with the wt
strain and this time the viable cells were recovered already 3, 6
and 12 hours post infection. Control bacteria (time 0) and recov-
ered bacteria were cultivated in SS medium and samples for RNA
as well as for Westernblot analysis were harvested at each time
point. As presented in Figure 4B, wt cells which were recovered
from macrophages produced and secreted Bsp22 protein already
3 hours upon infection indicating that relatively short-time inter-
action with immune cells was sufficient for activation of T3SS. In
addition, quantitative PCR analysis of RNA samples (Fig. 4C)
revealed that upon infection of macrophages, expression of bopN,
bsp22 and bteA genes was increased and thus copied the expres-
sion patterns observed in mouse-passaged strains.
Discussion
Recently we demonstrated that the hfqmutant of B. pertussis is
significantly attenuated in virulence and explained this observa-
tion by reduced production and/or secretion of the key virulence
factors adenylate cyclase and pertussis toxins by the mutant
Figure 4. Expression of T3SS is activated only in wt B. pertussis cells upon infection of macrophages. (A) Westernblot
analysis of Bsp22 protein levels in culture supernatants of wt or Dhfq bacteria recovered from RAW 264.7 macro-
phages. Bacteria recovered from macrophages 24 and 48 hours post infection were used to inoculate liquid cultures.
Samples of supernatants equivalent to 1 OD600 unit of initial culture were analyzed by immunoblotting using anti-
Bsp22 antibody. Relevant part of the membrane is shown. The result is representative of 3 experiments. (B) Western-
blot analysis of Bsp22 protein levels in culture supernatants of wt bacteria recovered from RAW 264.7 macrophages.
Viable bacteria, recovered from macrophages 3, 6 and 12 hours post infection, were used to inoculate liquid cul-
tures. Samples of supernatants equivalent to 1 OD600 unit of initial culture were analyzed by immunoblotting using
anti-Bsp22 antibodies. Relevant part of the membrane is shown. The result is representative of 3 experiments. (C)
RT-qPCR analysis of bopN, bsp22 and bteA transcripts levels in wt bacteria upon infection of macrophages. Differen-
tial expression analysis was performed using total RNA isolated from viable wt bacteria recovered from macro-
phages 3 (white columns), 6 (gray columns) and 12 hours (black columns) post infection. The values are means plus
standard deviations from 3 replicates.
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strain. Nevertheless, we realized that additional factors may be
responsible for the reduced virulence of the mutant. In the pres-
ent study, we therefore aimed at full characterization of the Hfq
regulon in B. pertussis with focus on factors involved in pathoge-
nicity. Transcriptional profiling has shown that Hfq is a global
regulator in B. pertussis as the deletion of hfq gene had a large
effect on gene expression with more than 10% of significantly
affected genes in all experiments. Among the most overrepre-
sented functional categories were “Information transfer,” “Energy
metabolism” and “Pathogenicity and Adaptation” categories.
Within the last category, comparative transcriptomic analysis
identified additional virulence factors that play important roles
in pathogenicity of B. pertussis and whose expression was signifi-
cantly downregulated in the Dhfq strain. Besides tracheal coloni-
zation factor tcfA, serum resistance factor brkA and
autotransporter vag8, a major part of the T3SS locus and T3SS
effector gene bteA were the most prominent virulence factors
downregulated in the hfq mutant. Quantitative PCR analysis
confirmed our transcriptomic data and provided further evidence
for Hfq involvement in T3SS expression. T3SS is one of the
most remarkable results of long-standing association of bacteria
with eukaryotic hosts and Hfq was reported to play specific roles
in T3SS activity in several pathogens.32-35 Therefore, in our next
experiments we concentrated on elucidation of the Hfq require-
ment for T3SS expression. Since the expression and production
of T3SS components such as Bsp22 in laboratory-adapted strains
is switched on only when the cells come into contact with the
host,22 both wt and Dhfq strains were passaged through mice.
Comparative analysis of transcriptomic profiles of Tohama I wt
and Dhfq cells recovered from mouse lung revealed that expres-
sion of several T3SS-specific genes including the bteA effector
was significantly induced in the wt strain, while this effect was
much less obvious in the mutant strain. Hfq is known to act at
the posttranscriptional level and therefore, we speculated that
Hfq may exert its effect rather indirectly via T3SS-specific regula-
tor BtrS encoded within the btr locus. However, we did not
observe any substantial difference in btrS gene expression
between wt and Dhfq strains. In fact, when we compared gene
expression profiles in bacteria recovered at day 12 and day 0, the
btrS expression was similarly increased in both wt (log2FC D 1.3;
P < 1 £ 10¡6) and Dhfq strains (log2FC D 0.9, P < 2£ 10¡5,
data not shown) suggesting that Hfq does not affect btrS expres-
sion and may employ another mechanism for T3SS activation.
Remarkably, our microarray data indicated that several putative
transcriptional factors are expressed at significantly reduced levels
in the hfq mutant. Although none of them belongs to the AraC
family of transcriptional activators which were shown to activate
T3SS in Yersinia,36 it would be of interest to determine their pos-
sible role in regulation of T3SS activity in B. pertussis. In this
study we confirmed the observation that a) in the laboratory-
adapted Tohama I strain, T3SS genes are actively transcribed in
vitro19,20 and b) while T3SS substrates such as Bsp22 protein are
not produced and secreted under in vitro growing condi-
tions,21,22,37 this ability can be regained upon passage in the
host.22,38 Furthermore, infection experiment showed that differ-
ential expression of the bsp22 gene translated into strikingly
altered levels of Bsp22 protein, a hallmark of T3SS functionality
in B. pertussis. Indeed, Westernblot analysis of bacteria recovered
from infected mice showed that in remarkable contrast to the wt
strain, Bsp22 protein did not accumulate in both cell lysates and
culture supernatants of the hfq mutant. The absence of Bsp22
protein in spite of reduced but detectable bsp22 transcription
indicated that Hfq affects T3SS functionality also at posttran-
scriptional level and consequently that Hfq is required for synthe-
sis of T3SS substrates. Recently, Hfq was reported to activate
synthesis of T3SS proteins via a small RNA in Y. pestis39 and it
would be of high importance to search for an analogous sRNA in
B. pertussis. It should be mentioned that in contrast to the Dhfq
strain, the btrU gene was found upregulated in the wt strain
upon infection, however, this factor was shown to be required for
secretion but not production of T3SS substrates.20 Therefore, its
reduced expression cannot explain undetectable accumulation of
Bsp22 protein inside the Dhfq cells. The precise mechanism of B.
pertussis T3SS activation upon contact with the host remains
unclear, however, the rapid activation of Bsp22 production upon
infection and persistence of this effect for several in vitro passages
suggests an epigenetic regulation.40
Among other virulence factors which were significantly
affected upon passage in mice, expression of tracheal colonization
factor tcfA was significantly reduced in the Dhfq strain when com-
pared to the wt strain. Recently, we reported that the hfq mutant
of B. pertussis exhibits a striking colonization defect when used in
mixed infection experiment with the wt strain.29 We understood
this result primarily as a consequence of reduced production of
adenylate cyclase toxin by the hfq mutant, however, herein pre-
sented data indicate that impaired expression of T3SS gene clus-
ter and tracheal colonization factor tcfA may as well significantly
contribute to reduced capacity of the hfq mutant to colonize
mouse lungs. In support, T3SS-deficient strains of B. bronchisep-
tica13,17,41 and B. pertussis21 were cleared much faster from the
respiratory tract of infected animals. Remarkably, we could reca-
pitulate our data obtained in in vivo infection experiments also in
in vitro infection model of murine macrophages. In contrast to
Dhfq cells, we observed increased expression of T3SS genes and
regained ability to produce Bsp22 protein in wt cells recovered
from RAW 264.7 macrophages. These data represent the first
evidence that T3SS can be activated also upon contact with
immune cells in vitro and therefore, we consider macrophage cells
as a very versatile and cost-effective infection model for gene
expression studies in B. pertussis.
Notably, the expression of autotransporter vag8 gene as deter-
mined by microarray and RT-qPCR analyses was also strongly
decreased in the hfq mutant and almost mirrored T3SS expres-
sion patterns under all tested conditions. Likewise, as evidenced
by immunoblotting, the production of Vag8 protein was signifi-
cantly reduced in the hfq mutant under standard laboratory con-
ditions. Furthermore, in contrast to Dhfq cells, the expression
and production of Vag8 was further increased in wt cells upon
infection and thereby again copied the T3SS expression pattern.
These results suggested that besides being regulated by the BvgAS
system the expression of non-adjacent bsc and vag8 genes is coor-
dinated by some yet unknown trans-encoded factor. Vag8 plays
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an important role during infection as it interacts with C1 esterase
inhibitor and confers to serum resistance.42 In addition, Vag8 is
presumed but not shown to be an accessory factor of T3SS20 and
our data would support this hypothesis. In contrast to other viru-
lence factors, the transcription of the ptx/ptl locus, encoding per-
tussis toxin and its secretion apparatus, was significantly
upregulated in the mutant. This observation is fully in line with
our previous study where we have shown that in spite of increased
transcription of ptx/ptl locus the amount of toxin secreted by the
hfq mutant was lower compared to the wt.29
While focused on virulence genes, microarray analysis revealed
a great number of Hfq-dependent genes which classified into sev-
eral categories. Within the set of genes with known function and
which were discovered to have higher transcript abundance in the
hfq mutant emerged genes encoding the components of ABC
transporter systems and amino acid transporters (“Surface
proteins” category) and 30S and 50S ribosomal proteins
(“Information transfer” category). Overexpression of both ABC
transporter and ribosomal genes seems to be a typical phenome-
non observed in hfq mutants of other bacteria.43-46 Among genes
displaying deregulated transcript levels in the hfq mutant were
also genes encoding several periplasmic and outer membrane pro-
teins. This was not surprising as we have previously observed
some differences in protein composition of the membrane frac-
tions between the wt and Dhfq strain.29 Several studies indicated
that lack of Hfq results in irregular production of OMPs which
affects the membrane integrity and cell envelope stability.33,47,48
Collectively, misregulation of ABC transporter genes, unbalanced
expression of ribosomal genes and aberrant expression/produc-
tion of OMPs might result in pleiotropic defects of hfq mutants
such as slower growth and therefore, may as well explain the
observed growth deficiency of the Tohama I hfq mutant.
Materials and Methods
Bacterial strains and growth conditions
The Bordetella pertussis Tohama I strain and its isogenic hfq
deletion mutant29 were grown on Bordet-Gengou agar (BGA)
plates supplemented with 15% defibrinated sheep blood for 3 to
4 days at 37C. For liquid cultures, bacteria were grown in modi-
fied Stainer-Scholte (SS) medium49 supplemented with 0.1%
cyclodextrin (Sigma) and 0.5% casamino acids (Difco) at 37C.
Samples for RNA isolation and protein analyses were taken at
exponential (OD600 1.3 and 0.7 for wt and Dhfq strains,
respectively) and early stationary (OD600 3.0 and 1.3 resp.)
phases of growth.
Immunoblotting
B. pertussis wt and Dhfq strains were cultivated in SS medium
at 37C and cell pellets from 1-ml aliquots were lysed and boiled
in sample buffer. For analysis of supernatant fractions, 20-ml ali-
quots of cell-free supernatants were filtered through 0.22 mm fil-
ters, precipitates obtained with 10% (w/v) trichloracetic acid
were washed with 80% acetone, dissolved in sample buffer and
boiled. Samples equivalent to 1 OD600 unit (supernatants) or 0.1
OD600 unit (whole-cell lysates) were separated on SDS-PAGE
gels and transferred on nitrocellulose membrane. Membranes
were probed with polyclonal antibodies raised against Bsp22
(laboratory stock), Vag8 (kindly provided by Dimitri Diavato-
poulos) and BrkA (kindly provided by Rachel Fernandez) fol-
lowed by incubation with corresponding IgG antibodies
conjugated with horse radish peroxidase. The antibody-antigen
complexes were visualized using SuperSignal West Femto chemi-
luminescent substrate (Thermo) according to standard protocol.
Preparation of the microarrays
Oligonucleotide probes were designed for 3554 annotated cod-
ing sequences of Bordetella pertussis Tohama I strain (BX470248.1,
GI:33591069) using the OligoArray v2.1 software.50 One oligonu-
cleotide for each of the annotated genes was designed except for the
non-coding genes (rRNA, tRNA and smRNA(ssrA)) and for the
transposase genes of IS elements. Out of the total 3554 probes
3462 were 60-nucleotides long with a Tm between 80 and 99C,
60 probes were 50-nucleotides long with a Tm between 70 and
99C and 32 probes were 45-nucleotides long with a Tm between
70 and 99C. Aminated oligonucleotides were obtained from
Sigma Aldrich and were resuspended in 20 mL of spotting solution
(sciSPOT-cDNA, Scenion) at a final concentration of 20 mM. 96
oligonucleotide probes (randomly selected among the 3554 probes
to be produced in duplicate) were mixed together, spotted as one
probe and used as positive control of hybridization (intrinsic control
providing an average intensity value for each study). All designed
probes including the control mixture of 96 probes and human gene
oligonucleotide-probes (negative controls) were spotted in duplicate
(non-adjacent) on aldehydsilane coated glass slides (Nexterion Slide
AL, Schott) using a QArray II spotter (Genetix) equipped with 12
ArrayHit 946MP3 pins. Spotting was done at 20-22C and in 50–
55% relative humidity. After spotting, glass slides were incubated at
120C for 1 h and then treated just before usage with 132 mM
NaBH4 in PBS containing 25% of ethanol for 30 minutes. The
slides were then washed twice in 0.2% SDS solution and twice in
distilled water before being dried by centrifugation.
RNA preparation and microarray analysis
B. pertussis wt and Dhfq cells were grown in 2 independent
biological replicates in SS medium and harvested by centrifuga-
tion (6000 rpm, 10 min, 4C) at exponential and stationary
phases of growth. Total RNA was extracted from pellets using
Trizol (Sigma) as recommended by the manufacturer and further
treated with DNase I (Promega) to remove any contaminating
genomic DNA. Purified RNA was checked for concentration and
integrity using the Bioanalyzer 2100 device (Agilent Technolo-
gies). Labeling with Cyanine-5 (Cy5) and Cyanine-3 (Cy3) was
performed by random primed reverse transcription starting from
10 mg of purified total RNA and using SuperscriptIII (Invitro-
gen) reverse transcriptase according to manufacturer protocol
and amplified cDNA was purified on Qiaquick PCR purification
kit (Qiagen). A mix of 1 mg of Cy5-cDNA C 1 mg of Cy3-
cDNA was then prepared in 490 mL of hybridization buffer (5£
SSC, 40% deionised formamide, 5£ Denhart’s buffer, 0.1%
SDS, 1 mM sodium pyrophosphate). The labeled mixture was
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used for hybridization using a gasket slide (Agilent Technologies)
for 14 to 16 h at 52C under agitation. For each sample a Cy5/
Cy3 dye-swap technical replicate starting from the same RNA
preparation was prepared and hybridized. After hybridization,
slides were subsequently washed at room temperature in 2£
SSC, 0.2%SDS for 5 minutes, in 0.5£ SSC for 10 minutes, in
0.05£ SSC for 5 minutes, and 0.01£ SSC for 2 minutes before
being dried and scanned using InnopScan700 (Innopsys). Back-
ground correction as well as within- and between-array normali-
zation51 was performed from raw data using LIMMA (Linear
Models for Microarray Data) package.52 After normalization,
identification of genes with significantly modulated expression
was performed using moderated Student’s t-test with empirical
Bayes shrinkage of standard errors.53 Statistics were corrected for
multiple testing using false-discovery rate approach. In order to
select genes significantly affected by hfq deletion, absolute log
fold change values (log2FC) of transcript abundance was set to at
least 1 (2-fold variation) and threshold for adjusted P-value (P)
of less than 0.05 was considered as indicative of significance. Sig-
nificantly affected genes were classified into functional categories
as assigned by Park and coworkers54 with following modifica-
tions. The categories “Degradation of small molecules” and
“Degradation of large molecules” were combined into category
“Degradation,” category “Pathogenicity, Adaptation and Chaper-
ones” was abbreviated to “Pathogenicity and Adaptation.” Genes
comprising T3SS bsc and btr loci were moved from “Surface
protein” category into “Pathogenicity and Adaptation” category.
Statistical significance of overrepresentation of functional categories
within the sets of genes with modified transcript abundance was
assessed using the Fisher exact test and corrected for multiple test-
ing using Benjamini and Hochberg method.55 Clustering of
microarray data was performed using MeV software from TIGR.56
Quantitative PCR (RT-qPCR)
To study the quantitative effects on gene expression, 1 mg of
total isolated RNA was reverse transcribed in duplicates into
cDNA following the manufacturer’s instructions in a 25-ml reac-
tion using the Reverse Transcription System (Promega). All pri-
mers (Table S7) were designed to anneal at 60C and were
analyzed for secondary structures and for cross-dimers in primer
pairs. RT-qPCR was performed on Bio-Rad CFX96 instrument
using SYBR Green JumpStartTM Taq ReadyMixTM (Sigma).
Briefly, 200 nmol/l of each primer together with 40 ng of reverse
transcribed RNA were used in a 20-ml qPCR reaction volume,
with an initial step at 95C for 2 min, followed by 40 cycles of
95C for 15 s, 60C for 30 s, 72C for 30 s, followed by record-
ing of the melting curve. The rpoB gene was used as reference
gene and relative gene expression was quantified using amplifica-
tion efficiency values.57
Infection of macrophages
B. pertussis cells were suspended in Dulbecco’s Modified Eagle’s
medium (DMEM) supplemented with 10% bovine serum albu-
min and the RAW 264.7 murine macrophages were infected at a
multiplicity of infection of 10 bacteria per cell (MOI 10). After
addition of bacteria, tissue culture plates were centrifuged for
5 min at 300 g to facilitate bacterial interaction with macrophage
cells. After 60 min of incubation at 37C with 5% CO2, non-
adherent bacteria were removed by 3 washing steps in DMEM.
Then, medium containing 100 mg/ml of polymyxin B sulfate was
added for 60 min at 37C with 5% CO2 to kill extracellular bac-
teria. Next, infected macrophages were washed with fresh medium
containing 30 mg/ml of polymyxin B sulfate and further incubated
at 37C with 5% CO2. In order to recover viable intracellular bac-
teria, infected macrophages were lysed with sterile water at differ-
ent times post infection as specified in legends of Figure 4A, B.
Lysates as well as bacteria which were not in contact with macro-
phages (time point 0; control sample) were plated onto BGA
plates and obtained bacteria were subsequently cultivated in SS
medium for RNA isolation and Westernblot analysis.
In vivo infection of mice
Four-week-old CD-1 Swiss outbred mice were obtained from
Charles River Laboratories and maintained under specific patho-
gen free conditions. Overnight cultures of B. pertussis strains were
diluted in sterile phosphate buffered saline (PBS, pH 7.4) to
adjust appropriate cell concentrations. Sublethal doses (1 £ 105
CFU/mouse) of both wt and Dhfq bacteria were administered
intranasally in suspensions of 50 ml and in parallel, the number
of delivered bacteria was determined by plating serial dilutions of
challenge suspensions on BGA plates. Cohorts of 15 animals
were challenged per strain and 3 mice per group were sacrificed
2 hours and 5, 8, 12 and 23 days post infection. The lungs were
removed aseptically and homogenized in 2 ml of PBS using a cell
grinder (Heidolph RZR2020). The resulting homogenates were
serially diluted with PBS and plated in duplicates on BGA plates
and colonies were counted to calculate the CFU values per
mouse. Student’s t test (SigmaPlot 1, Systat Software Inc., Cali-
fornia, USA) was used to compare the mean CFU values between
wt and Dhfq strains at each time point. Differences were consid-
ered significant at P values of  0.05. Recovered bacteria were
subcultured in SS medium and samples for RNA isolation and
westernblot analysis were taken at exponential phase of growth.
All animal experiments were approved by the Animal Welfare
Committee of the Institute of Microbiology of the ASCR, v.v.i.,
in Prague, Czech Republic. Handling of animals was performed
according to the Guidelines for the Care and Use of Laboratory
Animals, the Act of the Czech National Assembly, Collection of
Laws No. 149/2004, inclusive of the amendments on the Protec-
tion of Animals against Cruelty and Public Notice of the Minis-
try of Agriculture of the Czech Republic, Collection of Laws No.
207/2004, on care and use of experimental animals.
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